XML 27 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK BASED COMPENSATION
6 Months Ended
Sep. 30, 2017
STOCK BASED COMPENSATION  
STOCK BASED COMPENSATION
NOTE 12 - STOCK BASED COMPENSATION
 
Our board of directors, upon the recommendation of the previously constituted compensation committee of our board of directors, approved the 2016 TechPrecision Equity Incentive Plan, or the 2016 Plan, on November 10, 2016. Our stockholders approved the 2016 Plan at the Company’s Annual Meeting of Stockholders on December 8, 2016, and it applies to awards granted after that date. The 2016 Plan provides for a share reserve of 5,000,000 shares of common stock.
 
On April 4, 2017, we granted stock options to members of our board of directors to collectively purchase 200,000 shares of common stock at an exercise price of $0.74 per share, the closing stock market price on the date of grant. The weighted average fair value of the options on the grant date was $0.60 each. Forty percent of the options granted vested immediately. The remaining options will vest equally at the end of each quarter during fiscal 2018, beginning with the second quarter of fiscal 2018. The aggregate fair value of the stock options expensed during the six months ended September 30, 2017 was $84,138
 
The fair value of the options we grant is estimated using the Black-Scholes option-pricing model based on the closing stock prices at the grant date and the weighted average assumptions specific to the underlying options. Expected volatility assumptions are based on the historical volatility of our common stock. The average dividend yield over the historical period for which volatility was computed is zero. The risk-free interest rate was selected based upon yields of five-year U.S. Treasury issues. We used the simplified method for all grants to estimate the expected life of the option. We assume that stock options will be exercised evenly over the period from vesting until the awards expire. As such, the assumed period for each vesting tranche is computed separately and then averaged together to determine the expected term for the award. The assumptions utilized for options granted during the period were 110.1% for volatility, 1.88% for the risk free interest rate and approximately six years for the expected life. At September 30, 2017, there were 1,803,332 shares available for grant under the 2016 Plan.
 
The following table summarizes information about options for the six months ended September 30, 2017:
 
 
 
Number Of
 
Weighted
Average
 
Aggregate
Intrinsic
 
Weighted
Average
Remaining
Contractual Life
 
 
 
Options
 
Exercise Price
 
Value
 
(in years)
 
Outstanding at 3/31/2017
 
 
3,002,668
 
$
0.387
 
$
1,246,600
 
 
5.72
 
Granted
 
 
200,000
 
$
0.740
 
 
--
 
 
--
 
Forfeited
 
 
(6,000)
 
$
1.960
 
 
--
 
 
--
 
Outstanding at 9/30/2017
 
 
3,196,668
 
$
0.406
 
$
1,084,600
 
 
6.22
 
Vested or expected to vest at 9/30/2017
 
 
3,196,668
 
$
0.406
 
$
1,084,600
 
 
6.22
 
Exercisable and vested at 9/30/2017
 
 
2,576,668
 
$
0.394
 
$
934,600
 
 
6.22
 
 
The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on the last trading day of the second quarter of fiscal 2018 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on September 30, 2017. This amount changes based on the fair market value of the Company’s common stock.
 
The following table summarizes the status of our stock options outstanding but not vested for the six month period ended September 30, 2017:
 
 
 
Number of
Options
 
Weighted
Average
Exercise Price
 
Outstanding at 3/31/2017
 
 
833,334
 
$
0.266
 
Granted
 
 
200,000
 
$
0.740
 
Vested
 
 
(413,334)
 
$
0.208
 
Outstanding at 9/30/2017
 
 
620,000
 
$
0.458
 
 
The total fair value of shares vested during the period was $74,747. Other information relating to stock options outstanding at September 30, 2017 is as follows:
 
Range of Exercise Prices:
 
Options
Outstanding
 
Weighted
Average
Remaining
Contractual
Term (in years)
 
Weighted
Average
Exercise Price
 
Options
Exercisable
 
Weighted
Average
Exercise Price
$0.01-$1.00
 
 
3,021,668
 
 
6.92
 
$
0.34
 
 
2,401,668
 
$
0.31
$1.01-$1.96
 
 
175,000
 
 
2.84
 
$
1.59
 
 
175,000
 
$
1.59
Totals
 
 
3,196,668
 
 
 
 
 
 
 
 
2,576,668